TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 DKK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
0
|
0
|
589 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-126
|
-208
|
70 |
| EBITDA |
-126
|
-208
|
70 |
| Total assets |
99
|
160
|
435 |
| Current assets |
99
|
160
|
435 |
| Current liabilities |
45
|
50
|
84 |
| Equity capital |
53
|
109
|
350 |
| - share capital |
98
|
95
|
104 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
53.5%
|
68.1%
|
80.5% |
| Turnover per employee |
0
|
0
|
589 |
| Profit as a percentage of turnover | 11.9% | ||
| Return on assets (ROA) |
-127.3%
|
-130.0%
|
16.1% |
| Current ratio |
220.0%
|
320.0%
|
517.9% |
| Return on equity (ROE) |
-237.7%
|
-190.8%
|
20.0% |
| Change turnover |
0
|
-534
|
-87 |
| Change turnover % |
-100%
|
-13% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.